Denis Riendeau
Merck Frosst Centre for Therapeutic Research
16711 Trans Canada Highway
Kirkland
Quebec
Name/email consistency: high
- Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886. Riendeau, D., Aspiotis, R., Ethier, D., Gareau, Y., Grimm, E.L., Guay, J., Guiral, S., Juteau, H., Mancini, J.A., Méthot, N., Rubin, J., Friesen, R.W. Bioorg. Med. Chem. Lett. (2005)
- Evaluation of loxoprofen and its alcohol metabolites for potency and selectivity of inhibition of cyclooxygenase-2. Riendeau, D., Salem, M., Styhler, A., Ouellet, M., Mancini, J.A., Li, C.S. Bioorg. Med. Chem. Lett. (2004)
- Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. Riendeau, D., Percival, M.D., Brideau, C., Charleson, S., Dubé, D., Ethier, D., Falgueyret, J.P., Friesen, R.W., Gordon, R., Greig, G., Guay, J., Mancini, J., Ouellet, M., Wong, E., Xu, L., Boyce, S., Visco, D., Girard, Y., Prasit, P., Zamboni, R., Rodger, I.W., Gresser, M., Ford-Hutchinson, A.W., Young, R.N., Chan, C.C. J. Pharmacol. Exp. Ther. (2001)